This year Clarivate has recognized five NKI scientists as Highly Cited Researchers. All five have demonstrated a significant and broad influence in their field(s) of research over the past decade.
🎉 Congratulations! #HighlyCited2023

Read more ➡️ bit.ly/47AQt8D

Conducting research as a future medical oncologist with a group of fundamental researchers. An ideal way for PhD candidate Vincent de Jong to learn new things ➡️ bit.ly/47vuKiv Antoni van Leeuwenhoek @uniutrecht Alrijne Ziekenhuis

Stress appears to be linked to reduced efficacy of cancer immunotherapy, researchers from the Netherlands Cancer Institute discovered. They publish their findings in Nature Medicine today ➡️ bit.ly/40zmHPm

'A spot in the thyroid doesn't always require treatment. Sometimes, it's better to do nothing,' concludes PhD candidate Marceline Piek Antoni van Leeuwenhoek The Netherlands Cancer Institute @uniutrecht ➡️ bit.ly/3MESKYK

Check out this interesting review:

Baby’s may experience side effects from immunotherapy during pregnancy. Our researchers describe this rare phenomenon in a case study in NEJM this week, and developed a heel prick test. With UZ Leuven, @KU_Leuwen, Radboudumc, UMC Utrecht. ⬇️ bit.ly/3QPLoUu

To find a cure for every cancer, it is important to transition from locally organized clinical studies with slow accrual rates, to clinical studies across Europe. The NKI established a collaboration with Milena Cavic and her team in Serbia ➡️ bit.ly/4631yhT STEPUPIORS

Breast cancer patients who engaged in intensive physical activity during their treatment may experience less cardiovascular damage, PhD candidate Willeke Naaktgeboren found. She successfully defended her thesis on October 24. Antoni van Leeuwenhoek @uniutrecht Spaarne Gasthuis

Changpei Gan was the first in his family to travel to Europe for research purposes Antoni van Leeuwenhoek @uniutrecht. Now he is a PhD candidate in the Netherlands, investigating the functioning of an enzyme that breaks down medications ➡️ bit.ly/3SNhn9x

Great work Rick, congratulations!

🎉 Congratulations to Daniela Thommen, who will be joining Oncode Institute. She has been selected from a pool of 72 candidates based on the quality of her scientific work, expertise, and potential to contribute to Oncode Institute's mission.

Read more ➡️ bit.ly/3Mr6vdq

New findings from the #CancerGrandChallenges PRECISION team, published today in The BMJ, finds the association of ductal carcinoma in situ (DCIS) size and margin status with ipsilateral invasive breast cancer and ipsilateral DCIS to be small. The Netherlands Cancer Institute Cancer Research UK KWFKankerbestrijding (1/3)

For one of her experiments, PhD candidate Laura Bornes Antoni van Leeuwenhoek @uniutrecht once spent 43 hours hunched over the microscope. Her goal: uncovering the behaviors of cells. She will defend her thesis on November 3 ➡️ bit.ly/47bw6yO

Patients living with cancer across Europe face highly unequal access to innovative cancer medicines, a new study by the NKI and the EFPN found, with Time to access ranging from -1 years to 7.1 years after EMA approval ➡️ bit.ly/3QhV0pF

How do radioactive labeled medicines work in the human body? How do they remove tumors? Researcher Hinke Siebinga Antoni van Leeuwenhoek @uniutrecht tried to find an answer to these questions. She will defend her thesis on November 2
➡️ bit.ly/3sbOhWa

🎓 Congratulations to Benjamin Rowland who has recently been appointed professor of Genome Biology at Delft University of Technology. With his affiliated professorship he plans to build upon his existing collaborations and create opportunities for new ones bit.ly/3Qw4vTx

History was made last weekend at #ESMO2023 ! Both EV-pembro & Nivo-GemCis improve survival for patients with metastatic #BladderCancer . These are practice-changing results! #EAUPodcasts

Listen to Dr. Michiel van der Heijden presenting results from Checkmate-901:
👉ow.ly/mW2J50Q0tY3

🎉Congratulations to Leila Akkari who, together with researchers from UvA Amsterdam and Universiteit Leiden will receive an ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma. Read more: bit.ly/3QezqCk
#ERCSyG

By defending his thesis on DNA damage tolerance Ronak Shah Antoni van Leeuwenhoek UvA Amsterdam kept his promise to his mother: he became a doctor ➡️ bit.ly/3Qc9Vl3

📅On November 13, we host a LabLinks symposium in collaboration with Cell Press. LabLinks are free, in-person symposia organized by scientists and Cell Press editors. Various speakers will discuss ways to target the tumor microenvironment. Read more ➡️ bit.ly/3QvEDHx